If, as our data suggests, the apoptotic effect of Hsp90 inhibitors in small cell lung cancer is due to inhibition of other Hsp90 family members, such as Grp94 or Trap1, it will be important to develop new drugs that are optimized for selectivity and potency for these targets. Here, HSP90AA1 is linked to small cell lung carcinoma.